Calderon

Kidney Week 2012: Quality and Safety in Nephrology

October 31, 2012 // 1 Comment

Sharon Anderson, MD An increasing interest in the Nephrology community and the American Society of Nephrology is the quality and safety of nephrology care. “Choosing Wisely” is a good example. Developed in partnership with the American Board of [read more...]

Kidney Week 2012: Career Choices in Nephrology

October 31, 2012 // 1 Comment

Mark Rosenberg, MD 1. Over the years, academic faculty in nephrology has been decreasing in the US (by 5%) while the International Medical School graduated Faculty is fairly stable. This might be a phenotype that is at some risk of being lost. 2. US [read more...]

Senescence or Frailty? Are Chronic Disease Patients Different?

October 25, 2012 // 0 Comments

Chronic kidney disease (CKD) has long been known to negatively affect an individual’s quality of life. Identifying potentially modifiable risk factors may assist the physician in blunting, or even reversing this effect. In a recent article [read more...]

RASCAD: To stent or not to stent?

July 3, 2012 // 0 Comments

Whether renal revascularization reduces left ventricular hypertrophy in patients with coronary artery disease is uncertain. A randomized trial done by Marcantoni and colleagues from Italy evaluated this intervention (RASCAD trial). Dr. Carmelita [read more...]

Podcast: Incidence and Consequences of AKI in Kidney Transplant Recipients

March 20, 2012 // 2 Comments

In a recent article published in the American Journal of Kidney Diseases, Mehrotra and colleagues explore the epidemiology and outcomes of acute kidney injury (AKI) in kidney transplant recipients, focusing on AKI that is not due to acute [read more...]

Lessons to KEEP

March 13, 2012 // 1 Comment

The Kidney Early Evaluation Program (KEEP) is a service provided by the National Kidney Foundation to screen individuals for kidney disease. A recent article published as part of the KEEP supplement in the American Journal of Kidney Diseases reviews [read more...]

Ciprofloxacin and Rhabdomyolysis: A New Connection

February 21, 2012 // 1 Comment

Myoglobin-associated kidney injury is seen in severe rhabdomyolysis. Although certain drugs have been associated with this injury, ciprofloxacin is not a common agent. A recent teaching case was published in the American Journal of Kidney Diseases [read more...]

Podcast: Genetic Association and Gene-Gene Interaction Analyses in African American Dialysis Patients With Nondiabetic Nephropathy

January 12, 2012 // 1 Comment

Come listen to eAJKDs first ever podcast featuring Dr. Kellie Calderon as she interviews Dr. Barry Freedman, one of the authors of Genetic Association and Gene-Gene Interaction Analyses in African American Dialysis Patients With Nondiabetic [read more...]

Cardiac Biomarkers in CKD and ESRD: What to make of them?

November 29, 2011 // 2 Comments

Dr. Akshay S. Desai (AD), cardiologist from Harvard Medical School, spoke with Dr Kellie Calderon (eAJKD), eAJKD web advisory board member, on the use of cardiac biomarkers in chronic kidney disease (CKD). In CKD, elevations of cardiac biomarkers [read more...]

Sulodexide in Diabetic Nephropathy: Is There a Role for This Novel Agent?

November 22, 2011 // 0 Comments

Sulodexide is a low molecular weight heparin (LMWH) that has no measurable anticoagulant effect when taken orally. Preliminary studies have shown that sulodexide has a favorable effect on proteinuria in patients with diabetic nephropathy. This led [read more...]

AJKD Blog

Official Blog of the American Journal of Kidney Diseases